Market Scope

Trusted Partner of Industry and Medical Professionals for Market Data, Primary Research, Independent Perspective, & Objective Analysis

Latest Reports Latest News

Latest Market Reports

Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.

Latest Industry News & Trends

9/24/2021
BreakingPharmaRegulationRetina
US, UK Join EU in Approving First Ranibizumab Biosimilar Byooviz
US, UK Join EU in Approving First Ranibizumab Biosimilar Byooviz

The UK and US have joined the European Union in approving their first ranibizumab biosimilar, Byooviz, a Samsung Bioepis product that references Lucentis. EU approval was handed down Aug. 18. UK ap...

9/24/2021
BreakingDealsDiagnostic
Diagnostic Device Makers Luneau, Optovue Announce Merger
Diagnostic Device Makers Luneau, Optovue Announce Merger

Ophthalmic diagnostic device manufacturers Luneau Technology, of France, and Optovue, of Fremont, California, have announced an agreement to merge. Terms of the deal were not disclosed. The compani...

9/24/2021
BreakingClinical TrialDry EyePharma
Aerie Removes CEO After Dry Eye Candidate Misses Phase IIb Targets
Aerie Removes CEO After Dry Eye Candidate Misses Phase IIb Targets

Aerie Pharmaceuticals announced Sept. 21 that it had terminated longtime chairman and chief executive officer Vicente Anido, PhD, just days after the company reported that its dry eye candidate AR-...

9/24/2021
BreakingClinical TrialDry EyePharma
Nicox Blepharitis Candidate NCX 4251 Misses Endpoints in Phase IIb Trial  
Nicox Blepharitis Candidate NCX 4251 Misses Endpoints in Phase IIb Trial

French company Nicox announced Sept. 23 that NCX 4251, its candidate for blepharitis, failed to meet its primary or secondary endpoints in the MISSISSIPPI Phase IIb trial. NCX 4251 is a novel paten...

9/24/2021
BreakingCataractDealsPharma
Arctic Vision Adds Mydriatic Candidate MydCombi to Eyenovia License Deal

China’s Arctic Vision announced Sept. 16 that it would expand its exclusive license agreement with Eyenovia to include a third asset, mydriatic candidate MydCombi, for development and commercializa...

9/24/2021
AcquisitionsBreakingDealsGene TherapyRetina
Novartis Acquires Arctos Medical, Expanding Optogenetic Gene Therapy Pipeline
Novartis Acquires Arctos Medical, Expanding Optogenetic Gene Therapy Pipeline

Swiss company Novartis announced Sept. 21 that it had acquired Arctos Medical, developer of a potential optogenetic AAV gene therapy for inherited retinal disease. Financial details were not disclo...

9/24/2021
BreakingDealsGene TherapyRetina
Coave, Théa to Co-develop Gene Therapy Candidate for PDE6b-Associated RP
Coave, Théa to Co-develop Gene Therapy Candidate for PDE6b-Associated RP

French companies Coave Therapeutics and Théa have agreed to co-develop Coave’s gene therapy candidate CTx-PDE6b for patients with PDE6b-associated retinitis pigmentosa. Théa will make an upfront pa...

9/24/2021
BreakingDealsDry EyePharma
Glaukos Licenses Attillaps’ Compounds to Eradicate Demodex Mites
Glaukos Licenses Attillaps’ Compounds to Eradicate Demodex Mites

Glaukos announced Sept. 20 that it had entered into a licensing agreement with Attillaps Holdings granting Glaukos global rights to develop and commercialize Attillaps’ library of compounds that ta...

Physician Surveys

For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.

Complete a Survey

On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.

Benchmark Your Performance

Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.

View Market Insights & Analytics

Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.

Learn More Register Today

Market Scope Methodology

A Multi-Step Approach for Accurate & Timely Data

Proprietary data

  • 20+ years of physician survey data
  • Disease models
  • Cultivated database of physicians, ASCs, and hospitals
  • Insight from our team of in-house industry experts

Public data

  • Attendance and participation at major, worldwide meetings
  • Public health systems and registries
  • Clinical study data
  • Analysis of company-published financial reports

Join Market Scope Today

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more

Register A Clinical Account

A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.

United States
US Surveys
May select more than one